Friday, December 5, 2025
Search

Niu Technologies And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via News Editorial Team

November 8, 2021

Niu Technologies  And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Niu Technologies (NIU), AXT (AXTI), Entravision Communications Corporation (EVC) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Niu Technologies (NIU)

60.3% sales growth and 23.03% return on equity

Niu Technologies designs, manufactures, and sells smart electric-scooters in the People's Republic of China.

Niu Technologies's sales growth this year is anticipated to be 59.4% and 47.2% for next year.

Year-on-year quarterly revenue growth grew by 46.5%, now sitting on 3.06B for the twelve trailing months.

Volume

Today's last reported volume for Niu Technologies is 388124 which is 35.91% below its average volume of 605629.

Niu Technologies's sales growth for the next quarter is 60.3%. The company's growth estimates for the current quarter and the next is 55.6% and 61.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.03%.

Volatility

Niu Technologies's last day, last week, and last month's current volatility was 0.37%, 1.96%, and 2.20%, respectively.

Niu Technologies's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.31% (day), 3.90% (last week), and 3.92% (last month), respectively.

Niu Technologies's Stock Yearly Top and Bottom Value

Niu Technologies's stock is valued at $26.15 at 05:22 EST, way under its 52-week high of $53.38 and way higher than its 52-week low of $21.08.

Niu Technologies's Moving Average

Niu Technologies's worth is higher than its 50-day moving average of $24.95 and below its 200-day moving average of $28.66.

2. AXT (AXTI)

28.7% sales growth and 6.42% return on equity

AXT, Inc. designs, develops, manufactures, and distributes compound and single element semiconductor substrates.

AXT's sales growth this year is expected to be 41.5% and 10.3% for next year.

Year-on-year quarterly revenue growth grew by 35.8%, now sitting on 126.7M for the twelve trailing months.

Volume

Today's last reported volume for AXT is 67248 which is 85.45% below its average volume of 462493.

AXT's sales growth for the next quarter is 28.7%. The company's growth estimates for the present quarter and the next is 400% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.42%.

Volatility

AXT's last day, last week, and last month's current volatility was 4.80%, 3.09%, and 2.05%, respectively.

AXT's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.85% (day), 5.76% (last week), and 4.38% (last month), respectively.

AXT's Stock Yearly Top and Bottom Value

AXT's stock is valued at $9.24 at 05:22 EST, way under its 52-week high of $15.84 and way above its 52-week low of $6.12.

AXT's Moving Average

AXT's value is way higher than its 50-day moving average of $8.27 and under its 200-day moving average of $9.53.

3. Entravision Communications Corporation (EVC)

25.4% sales growth and 17.17% return on equity

Entravision Communications Corporation operates as a media company that reaches and engages Hispanics across acculturation levels and media channels primarily in the United States, Spain, Mexico, Argentina, and other Latin America countries.

Entravision Communications Corporation's sales growth this year is anticipated to be 115.7% and 12.3% for next year.

Year-on-year quarterly revenue growth grew by 295.4%, now sitting on 561.95M for the twelve trailing months.

Entravision Communications Corporation's sales growth is a negative 0% for the ongoing quarter and 25.4% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 10% and negative -36.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.17%.

Volatility

Entravision Communications Corporation's last day, last week, and last month's current volatility was 2.71%, 2.38%, and 1.90%, respectively.

Entravision Communications Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.93% (day), 5.06% (last week), and 4.31% (last month), respectively.

Entravision Communications Corporation's Stock Yearly Top and Bottom Value

Entravision Communications Corporation's stock is valued at $0.00 at 05:22 EST, below its 52-week low of $1.89.

Entravision Communications Corporation's Moving Average

Entravision Communications Corporation's value is under its 50-day moving average of $7.51 and under its 200-day moving average of $6.12.

4. Federal Realty Investment Trust (FRT)

7.2% sales growth and 6.07% return on equity

Federal Realty is a recognized leader in the ownership, operation and redevelopment of high-quality retail-based properties located primarily in major coastal markets from Washington, D.C. to Boston as well as San Francisco and Los Angeles.

Federal Realty Investment Trust's sales growth this year is expected to be 8.8% and 7.4% for next year.

Year-on-year quarterly revenue growth grew by 34.5%, now sitting on 873.25M for the twelve trailing months.

Volume

Today's last reported volume for Federal Realty Investment Trust is 611293 which is 44.74% above its average volume of 422334.

Federal Realty Investment Trust's sales growth for the next quarter is 7.2%. The company's growth estimates for the ongoing quarter and the next is 200% and negative -64.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.07%.

Volatility

Federal Realty Investment Trust's last day, last week, and last month's current volatility was 3.19%, 1.54%, and 0.91%, respectively.

Federal Realty Investment Trust's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.50% (day), 2.40% (last week), and 1.88% (last month), respectively.

Federal Realty Investment Trust's Stock Yearly Top and Bottom Value

Federal Realty Investment Trust's stock is valued at $128.46 at 05:22 EST, under its 52-week high of $128.86 and way higher than its 52-week low of $67.90.

Federal Realty Investment Trust's Moving Average

Federal Realty Investment Trust's value is above its 50-day moving average of $120.87 and above its 200-day moving average of $117.86.

5. Royalty Pharma (RPRX)

6.2% sales growth and 19.76% return on equity

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.

Royalty Pharma's sales growth this year is anticipated to be 5.6% and 3.5% for next year.

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 2.24B for the twelve trailing months.

Volume

Today's last reported volume for Royalty Pharma is 1662890 which is 23.71% below its average volume of 2179950.

Royalty Pharma's sales growth for the next quarter is 6.2%. The company's growth estimates for the present quarter and the next is 41.7% and 171.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.76%.

Volatility

Royalty Pharma's last day, last week, and last month's current volatility was 0.18%, 2.41%, and 1.72%, respectively.

Royalty Pharma's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.77% (day), 3.36% (last week), and 2.81% (last month), respectively.

Royalty Pharma's Stock Yearly Top and Bottom Value

Royalty Pharma's stock is valued at $39.52 at 05:22 EST, way below its 52-week high of $53.23 and way higher than its 52-week low of $34.86.

Royalty Pharma's Moving Average

Royalty Pharma's value is above its 50-day moving average of $37.17 and under its 200-day moving average of $39.97.

6. Illinois Tool Works (ITW)

6.1% sales growth and 79.64% return on equity

Illinois Tool Works Inc. manufactures and sells industrial products and equipment worldwide.

Illinois Tool Works's sales growth this year is anticipated to be 15.7% and 5.8% for next year.

Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 12.89B for the twelve trailing months.

Volume

Today's last reported volume for Illinois Tool Works is 812358 which is 8.89% below its average volume of 891713.

Illinois Tool Works's sales growth for the next quarter is 6.1%. The company's growth estimates for the ongoing quarter and the next is 14.8% and 7.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 79.64%.

Volatility

Illinois Tool Works's last day, last week, and last month's current volatility was 1.46%, 0.69%, and 0.80%, respectively.

Illinois Tool Works's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.79% (day), 1.73% (last week), and 1.61% (last month), respectively.

Illinois Tool Works's Stock Yearly Top and Bottom Value

Illinois Tool Works's stock is valued at $234.07 at 05:22 EST, under its 52-week high of $242.07 and way higher than its 52-week low of $192.89.

Illinois Tool Works's Moving Average

Illinois Tool Works's worth is above its 50-day moving average of $219.06 and above its 200-day moving average of $226.52.